mRNA Technology - Search News

mRNA, vaccine research

Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 percent compared to standard treatment in a late-stage trial, pharmaceutical...

· 2d · on MSN

How mRNA vaccines could help the immune system fight cancer cells

· 2d · on MSN

Experimental mRNA vaccine cuts risk that melanoma returns by 42%

Wall Street Journal · 1d

Moderna’s Cancer Vaccine Success Doesn’t Live Up to Early Hype

To the scientific world, Moderna’s MRNA -23.09% cancer vaccine’s results proved that a highly personalized, immune-targeting medication can work.

· 1d

A personalized cancer vaccine could be available as soon as 2027. Here’s what we know

· 1d

Merck and Moderna release promising data on cancer vaccine trial

· 1d

A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study

Adding it to a standard post-surgery treatment reduced by 42 per cent the risk of melanoma returning two years after surgery, according to the most advanced study to date of this new strategy for figh...

· 1d

These Melanoma Patients Got a Vaccine Made for Their Own Tumors. 2 Years Later, 82% Are Still Cancer-Free

Yahoo · 1d

Custom-built skin cancer vaccine almost halves death risk

Medical Xpress

Modified mRNA vaccine masquerades as a virus to trick the body into stronger immunity

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly enhance their effectiveness. The innovation could become ...

Yahoo Finance

Moderna and BioNTech pioneered mRNA vaccines. But who will make a mark in therapeutics?

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices ...

Phys.org

A generative AI platform for mRNA therapeutics

Raina Biosciences Inc. (Raina), an mRNA technology and therapeutics company, has released data from its generative AI platform in Science. The data supports Raina's pioneering approach to mRNA design using its GEMORNA platform to generate novel sequences ...

newswire

Moderna and Coursera Launch Free Course on mRNA Technology

, August 14, 2024 (Newswire.com) - Moderna, Inc. (NASDAQ:MRNA) and Coursera (NYSE:COUR) today announced a partnership to launch mRNAs as Medicines, a three-module course designed by experts at Moderna that offers a comprehensive understanding of mRNA ...

Advances in mRNA & LNP technology for in vivo CAR-T therapy, Upcoming Webinar Hosted by Xtalks

In vivo CAR-T therapy requires durable, yet transient CAR expression coupled with efficient, T cell-specific delivery. This webinar will focus on how innovations in RNA design and next-generation lipid nanoparticle (LNP) technology are enabling direct in vivo engineering of T cells,

1monOpinion

Sally C. Pipes: The first mRNA flu vaccine may be just the beginning

Skepticism about the government’s pandemic response is one thing. Writing off mRNA vaccine technology is another.

New Zealand effort to reduce livestock emissions revives mRNA vaccine falsehoods

A New Zealand agency has invested in a US startup developing a vaccine to reduce livestock methane emissions, but the jab does not use mRNA, contrary to conspiratorial posts online reviving Covid-era falsehoods about the technology being harmful.